Camilla Mohlin

Camilla Mohlin is a researcher at Linnaeus University, affiliated with the Faculty of Health and Life Sciences and the Department of Chemistry and Biomedical Sciences. Her work primarily focuses on the complement system, age-related macular degeneration (AMD), and retinal degeneration.

Her ongoing research projects include:

• Advanced Materials for Personalized Medicine & Diagnostics (AMPMeD)
• Chronic inflammation in AMD patients treated with anti-VEGF injections
• Complement regulators in AMD pathophysiology

Key publication trends span immunology, neuroscience, and nanomedicine, with sub-fields like complement regulation, retinal neuroinflammation, and nanoparticle toxicity.

She has published in journals such as:

• Graefe's Archives for Clinical and Experimental Ophthalmology (2025)
• Frontiers in Immunology (2023)
• Journal of Molecular Biology (2023)